1. Home
  2. KALU vs AVDL Comparison

KALU vs AVDL Comparison

Compare KALU & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaiser Aluminum Corporation

KALU

Kaiser Aluminum Corporation

HOLD

Current Price

$113.77

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.44

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALU
AVDL
Founded
1946
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
2.1B
IPO Year
1991
1996

Fundamental Metrics

Financial Performance
Metric
KALU
AVDL
Price
$113.77
$21.44
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$95.67
$18.38
AVG Volume (30 Days)
214.2K
2.2M
Earning Date
10-22-2025
11-04-2025
Dividend Yield
2.70%
N/A
EPS Growth
58.01
N/A
EPS
5.17
N/A
Revenue
$3,209,400,000.00
$248,517,000.00
Revenue This Year
$12.83
$65.47
Revenue Next Year
$12.98
$30.88
P/E Ratio
$22.06
N/A
Revenue Growth
7.69
79.88
52 Week Low
$46.81
$6.38
52 Week High
$115.33
$23.57

Technical Indicators

Market Signals
Indicator
KALU
AVDL
Relative Strength Index (RSI) 75.60 59.35
Support Level $106.13 $21.36
Resistance Level $110.94 $21.46
Average True Range (ATR) 4.11 0.09
MACD 0.64 -0.17
Stochastic Oscillator 93.94 56.60

Price Performance

Historical Comparison
KALU
AVDL

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: